HOUSE-DUST MITE IMMUNOTHERAPY RESULTS IN A DECREASE IN DER-P 2-SPECIFIC IFN-GAMMA AND IL-4 EXPRESSION BY CIRCULATING T-LYMPHOCYTES

Citation
Rm. Obrien et al., HOUSE-DUST MITE IMMUNOTHERAPY RESULTS IN A DECREASE IN DER-P 2-SPECIFIC IFN-GAMMA AND IL-4 EXPRESSION BY CIRCULATING T-LYMPHOCYTES, Clinical and experimental allergy, 27(1), 1997, pp. 46-51
Citations number
11
Categorie Soggetti
Allergy,Immunology
ISSN journal
09547894
Volume
27
Issue
1
Year of publication
1997
Pages
46 - 51
Database
ISI
SICI code
0954-7894(1997)27:1<46:HMIRIA>2.0.ZU;2-X
Abstract
Background Allergen-specific immunotherapy (IT) can be an important ad junctive therapy in the treatment of allergic disorders. Although it h as now been used for over 80 yr, the precise mechanism of action remai ns unclear. Recently a number of studies have shown that cytokine prod uction may be modified by IT, but different protocols have been used a nd different results obtained. Objectives The aims of the present stud y were: (1) to document the allergen-specific expression of interleuki n-4 (IL-4) and interferon-gamma (IFN-gamma) by peripheral blood cells in both untreated house dust mite (HDM) allergic patients (non-IT) and following at least 10 months of HDM-specific IT (post-IT); and (2) to determine whether alterations in these critical regulatory cytokines correlated with the clinical outcome of IT. Methods IT was undertaken with nine fortnightly subcutaneous injections of increasing amounts of a Dermatophagoides pteronyssinus (Dpt) extract, reaching a final dose of 10 000 PNU. This was followed by 6- to 8-monthly maintenance injec tions of 5000 PNU. For cytokine measurement, mononuclear cells were se parated from peripheral blood and stimulated with the major Dpt allerg en, Der p 2, for 18 h, after which mRNA was isolated and IL-4 and IFN- gamma cDNA were amplified by polymerase chain reaction (PCR). The pres ence of the particular cytokine was determined by visualization follow ing electrophoresis on an agarose gel. The study was observational in nature being open and without a placebo group.Results Fifteen Dpt-sens itive patients who had not received HDM IT (non-IT), and 16 who had, w ere studied. In the non-IT group, 80% expressed IL-4 and 75% expressed IFN-gamma. In those post-IT, only 12.5% expressed IL-4 and 19% IFN-ga mma. The two patients still expressing IL-4 post-IT had had very littl e clinical response. Six patients were studied both pre- and post-IT. Prior to IT, three were positive for both cytokines, two positive for IL-4 alone and one for IFN-gamma. Post-IT, all six were negative for I L-4 and five were negative for IFN-gamma. Conclusion Allergen-specific IT results in a reduction in expression of the critical cytokines IL- 4 and IFN-gamma in circulating lymphocytes. It is possible that this i s a contributary mechanism in the beneficial effect of IT.